Compound information
- Natural Products
- ZC2805562
- Molecular Formula
- C28H30N2O7
- Molecular Weight
- 506.2053013 g/mol
- Structure
-
- IUPAC Name
- (2R)-2-(benzyloxycarbonylamino)-5-[bis(4-methoxyphenyl)methylamino]-5-oxo-pentanoic acid
- InChI
- InChI=1S/C28H30N2O7/c1-35-22-12-8-20(9-13-22)26(21-10-14-23(36-2)15-11-21)30-25(31)17-16-24(27(32)33)29-28(34)37-18-19-6-4-3-5-7-19/h3-15,24,26H,16-18H2,1-2H3,(H,29,34)(H,30,31)(H,32,33)/t24-/m1/s1
- InChI Key
- NXGRPCWLXRUYOF-XMMPIXPASA-N
- SMILES
- COc1ccc(C(NC(=O)CC[C@@H](NC(=O)OCc2ccccc2)C(=O)O)c2ccc(OC)cc2)cc1
- Source
- ZINC000008626845
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 37 | Ring Count | 3 |
Heteroatom Count | 9 | Rotatable Bond Count | 12 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 123.19 Å2 | LogP | 3.346 |
LogS | -4.124 | LogD | 3.422 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.006 | Pgp substrate | 0.082 |
HIA | 0.955 | F20 % | 0.014 |
F30 % | 0.012 | Caco-2 | -5.047 |
MDCK | -5.136 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.07 | PPB | 99.224 |
VD | 0.176 | Fu | 2.037 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.007 | CYP1A2 substrate | 0.691 |
CYP2A6 substrate | 0.475 | CYP2B6 substrate | 0.384 |
CYP2C19 inhibitor | 0.871 | CYP2C19 substrate | 0.803 |
CYP2C8 substrate | 0.892 | CYP2C9 inhibitor | 0.833 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.016 |
CYP2D6 substrate | 0.815 | CYP2E1 substrate | 0.353 |
CYP3A4 inhibitor | 0.334 | CYP3A4 substrate | 0.482 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.355 | CL | 1.44 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.077 | Hepatotoxicity | 0.979 |
Mutagenicity | 0.013 | Rat Oral Acute Toxicity | 0.105 |
FDAMDD | 0.319 | Skin Sensitization | 0.034 |
Carcinogenicity | 0.016 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.01 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.754 | IGC50 | 2.647 |
LC50FM | 1.614 | LC50DM | 3.465 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.333 | NR-AR-LBD | 0.308 |
NR-AhR | 0.024 | NR-Aromatase | 0.026 |
NR-ER | 0.375 | NR-ER-LBD | 0.309 |
NR-PPAR-gamma | 0.649 | SR-ARE | 0.239 |
SR-ATAD5 | 0.446 | SR-HSE | 0.114 |
SR-MMP | 0.026 | SR-p53 | 0.074 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.